Page 286 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 286
Fatty Liver Disease: Experimental (Cont.)
YI P0951 MIR-21 INHIBITION AND FXR ACTIVATION
SYNERGISTICALLY AMEILORATE DISEASE
PATHOGENESIS IN A MOUSE MODEL OF NAFLD
Pedro M. Rodrigues*, Marta B. Afonso, André L. Simão, Marta Caridade,
Catarina C. Carvalho, Alexandre Trindade, António Duarte,
Pedro M. Borralho, Mariana V. Machado, Helena Cortez-Pinto,
Cecília M. P. Rodrigues, Rui E. Castro, Portugal
YI P0952 TRANSIENT HEPATIC OVEREXPRESSION OF THE
INSULINE-LIKE GROWTH FACTOR 2 (IGF2) INDUCES LIPID
DROPLET FORMATION
Sonja M. Kessler*, Stephan Laggai, Elien Van Wonterghem,
Roosmarijn E. Vandenbroucke, Manfred Ogris, Claude Libert,
Alexandra K. Kiemer, Germany
YI P0953 FXR RESISTANCE CHARACTERIZES HUMAN AND MOUSE
MODEL OF NASH
ePOSTERS Sophie Cazanave*, Robert Vincent, Jyoti Srivastava, Amon Asgharpour,
Mulugeta Sheneshaw, Faridoddin Mirshahi, Divya Prasanna Kumar,
Puneet Puri, Devanand Sarkar, Arun Sanyal, The United States
YI P0954 PU-ERH TEA EXTRACT AMELIORATES HIGH-FAT DIET-
INDUCED NONALCOHOLIC STEATOHEPATITIS AND
INSULIN RESISTANCE BY ENHANCING HEPATIC STAT3
PHOSPHORYLATION IN MICE
Xian B. Cai*, Chong Y. Fang, Shuhei Hayashi, Ming M. Zhao,
Shuhei Nishiguchi, Hiroko Tsutsui, Jun Sheng, Japan
YI P0955 COMBINE THERAPY WITH LOSARTAN AND YC-1
PRODUCES BROWNING PHENOMENON OF WHITE
ADIPOSE MASS IN OB/OB MICE
Hsuan Miao Liu*, Tzung-Yan Lee, Jyh-Fei Liao, Han-Chieh Lin, Taiwan
YI P0956 MIR-22 DEFICIENCY EXACERBATES SYSTEMIC AND
HEPATIC METABOLIC DISORDERS ASSOCIATED WITH
DIET-INDUCED OBESITY IN MICE
Anne-Sophie Berthomieu*, Dorothea Portius, Daniel Abegg,
Pia Rantakari, Fu-Ping Zhang, Matti Poutanen, Didier Picard, Serge Nef,
Alexander Adibekian, Michelangelo Foti, Switzerland
286 The International Liver Congress™ 2015 • ILC Programme
YI P0951 MIR-21 INHIBITION AND FXR ACTIVATION
SYNERGISTICALLY AMEILORATE DISEASE
PATHOGENESIS IN A MOUSE MODEL OF NAFLD
Pedro M. Rodrigues*, Marta B. Afonso, André L. Simão, Marta Caridade,
Catarina C. Carvalho, Alexandre Trindade, António Duarte,
Pedro M. Borralho, Mariana V. Machado, Helena Cortez-Pinto,
Cecília M. P. Rodrigues, Rui E. Castro, Portugal
YI P0952 TRANSIENT HEPATIC OVEREXPRESSION OF THE
INSULINE-LIKE GROWTH FACTOR 2 (IGF2) INDUCES LIPID
DROPLET FORMATION
Sonja M. Kessler*, Stephan Laggai, Elien Van Wonterghem,
Roosmarijn E. Vandenbroucke, Manfred Ogris, Claude Libert,
Alexandra K. Kiemer, Germany
YI P0953 FXR RESISTANCE CHARACTERIZES HUMAN AND MOUSE
MODEL OF NASH
ePOSTERS Sophie Cazanave*, Robert Vincent, Jyoti Srivastava, Amon Asgharpour,
Mulugeta Sheneshaw, Faridoddin Mirshahi, Divya Prasanna Kumar,
Puneet Puri, Devanand Sarkar, Arun Sanyal, The United States
YI P0954 PU-ERH TEA EXTRACT AMELIORATES HIGH-FAT DIET-
INDUCED NONALCOHOLIC STEATOHEPATITIS AND
INSULIN RESISTANCE BY ENHANCING HEPATIC STAT3
PHOSPHORYLATION IN MICE
Xian B. Cai*, Chong Y. Fang, Shuhei Hayashi, Ming M. Zhao,
Shuhei Nishiguchi, Hiroko Tsutsui, Jun Sheng, Japan
YI P0955 COMBINE THERAPY WITH LOSARTAN AND YC-1
PRODUCES BROWNING PHENOMENON OF WHITE
ADIPOSE MASS IN OB/OB MICE
Hsuan Miao Liu*, Tzung-Yan Lee, Jyh-Fei Liao, Han-Chieh Lin, Taiwan
YI P0956 MIR-22 DEFICIENCY EXACERBATES SYSTEMIC AND
HEPATIC METABOLIC DISORDERS ASSOCIATED WITH
DIET-INDUCED OBESITY IN MICE
Anne-Sophie Berthomieu*, Dorothea Portius, Daniel Abegg,
Pia Rantakari, Fu-Ping Zhang, Matti Poutanen, Didier Picard, Serge Nef,
Alexander Adibekian, Michelangelo Foti, Switzerland
286 The International Liver Congress™ 2015 • ILC Programme
